医学
内科学
禁忌症
耐火材料(行星科学)
心脏病学
病理
物理
替代医学
天体生物学
作者
Marco Di Battista,Alessandra Della Rossa,Marta Mosca
标识
DOI:10.3899/jrheum.2024-0103
摘要
Raynaud phenomenon (RP) and digital ulcers (DUs) are the main signs of digital vasculopathy in systemic sclerosis (SSc). Selexipag is an oral prostacyclin agonist approved for SSc-related pulmonary arterial hypertension. Following our previous preliminary short-course report, we herein present long-term data on selexipag safety and efficacy in the treatment of SSc digital vasculopathy.
科研通智能强力驱动
Strongly Powered by AbleSci AI